A Predictive NAM for Developmental Toxicity Testing: An Automated, Repeatable DevTox Assay Using Microfluidics and Machine Learning-Based Approaches

Posted on October 8, 2025October 14, 2025 by Gina Carrion

Developmental toxicity (DevTox) occurs when a chemical or substance disrupts an organism’s normal growth and developmental processes. The mechanisms underlying developmental toxicity may include structural malformations, molecular growth pathway interference, Read more about A Predictive NAM for Developmental Toxicity Testing: An Automated, Repeatable DevTox Assay Using Microfluidics and Machine Learning-Based Approaches[…]

Unlocking the Mysteries of Protein Aggregation: Insights from C. elegans

Posted on July 31, 2025October 14, 2025 by Gina Carrion

How Dietary and Pharmacological Interventions Can Slow Progression of Neurodegenerative Diseases Protein homeostasis, or proteostasis, is essential for maintaining cellular function by ensuring proper protein folding, trafficking, and degradation. Disruption Read more about Unlocking the Mysteries of Protein Aggregation: Insights from C. elegans[…]

Schematic showing immobilization of organoids for high-resolution imaging in the organoidChip

NIH Pushes Human-Centered Research; vivoVerse Showcases Organ-on-a-Chip Solutions

Posted on May 7, 2025October 14, 2025 by Gina Carrion

[Austin, Texas] – The National Institutes of Health (NIH) has announced a major shift in its research priorities, emphasizing the development and adoption of human-based technologies over traditional animal Read more about NIH Pushes Human-Centered Research; vivoVerse Showcases Organ-on-a-Chip Solutions[…]

Tiny Titans of Science: The Nobel-Worthy Science of C. elegans

Posted on May 1, 2025October 14, 2025 by Gina Carrion

They may be tiny, but Caenorhabditis elegans (C. elegans) are titans in the world of science. Named for their elegant, wave-like movements, these microscopic worms have quietly powered some of Read more about Tiny Titans of Science: The Nobel-Worthy Science of C. elegans[…]

Why C. elegans Is a Powerful Model Organism in Biomedical Research

Posted on April 25, 2025October 14, 2025 by Gina Carrion

Caenorhabditis elegans (C. elegans), a tiny transparent roundworm, has become one of the most widely used model organisms in scientific research. First introduced to the laboratory by Sydney Brenner Read more about Why C. elegans Is a Powerful Model Organism in Biomedical Research[…]

The FDA’s Shift from Animal Testing: Role of Small Model Organisms as NAMs

Posted on April 16, 2025October 14, 2025 by Gina Carrion

On April 10, 2025, the FDA announced a major policy shift: creating a roadmap outlining a strategic approach to reduce animal testing in preclinical safety studies. This transition prioritizes New Read more about The FDA’s Shift from Animal Testing: Role of Small Model Organisms as NAMs[…]

vivoVerse revolutionizes developmental toxicity testing with AI-assisted high-throughput C. elegans image analysis

Posted on January 15, 2025October 14, 2025 by Gina Carrion

Austin, TX — vivoVerse is proud to announce the publication of groundbreaking research that sets a new benchmark for developmental toxicity (DevTox) testing. This study highlights the transformative potential of Read more about vivoVerse revolutionizes developmental toxicity testing with AI-assisted high-throughput C. elegans image analysis[…]

C. elegans scientists awarded 2014 Nobel Prize in Medicine for their pioneering work discovering microRNA

Posted on October 28, 2024October 14, 2025 by Gina Carrion

The 2024 Nobel Prize in Physiology or Medicine was awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA, a small non-coding RNA molecule that plays a crucial Read more about C. elegans scientists awarded 2014 Nobel Prize in Medicine for their pioneering work discovering microRNA[…]

vivoVerse awarded NIH/NIEHS grant to develop novel approaches for developmental neurotoxicity testing

Posted on July 9, 2024October 14, 2025 by Gina Carrion

vivoVerse is excited to announce it has been awarded a Phase I SBIR grant from the National Institute of Environmental Health Sciences (NIEHS) for the continued development of the company’s Read more about vivoVerse awarded NIH/NIEHS grant to develop novel approaches for developmental neurotoxicity testing[…]